Deutsche Bank
RLYB icon

Deutsche Bank’s Rallybio RLYB Stock Holding History

Deutsche Bank’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,543
Closed -$41.6K – 3690
2023
Q3 		$41.6K Hold
1,543
– – ﹤0.01% 3440
2023
Q2 		$69.9K Sell
1,543
-512
-25% -$25.1K ﹤0.01% 3401
2023
Q1 		$93.9K Buy
2,055
+1,038
+102% +$53.6K ﹤0.01% 3358
2022
Q4 		$53.5K Buy
1,017
+13
+1% +$767 ﹤0.01% 3554
2022
Q3 		$116K Sell
1,004
-133
-12% -$11.8K ﹤0.01% 3244
2022
Q2 		$69K Sell
1,137
-73
-6% -$5.49K ﹤0.01% 3662
2022
Q1 		$68K Buy
1,210
+664
+122% +$54.9K ﹤0.01% 3731
2021
Q4 		$42K Buy
546
+29
+6% +$3.37K ﹤0.01% 4003
2021
Q3 		$73K Buy
+517
New +$60.6K ﹤0.01% 4018

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Deutsche Bank's RLYB Position: Q4 2023 in Review

Deutsche Bank sold out of Rallybio (RLYB) in Q4 2023, closing a stake of 1,543 shares — an estimated $41.6K sold.

Deutsche Bank first reported a position in RLYB in Q3 2021 and held it in 9 quarters. The position peaked at $116K in Q3 2022. 54 funds tracked by Wall St. Rank hold RLYB as of Q4 2023.

  • Deutsche Bank reported no remaining Rallybio position as of Q4 2023 after selling out during the quarter.
  • Deutsche Bank sold 1,543 Rallybio shares in Q4 2023, an estimated $41.6K.
  • Deutsche Bank first reported a position in Rallybio in Q3 2021 and held it in 9 quarters.
  • Deutsche Bank's Rallybio position peaked at $116K in Q3 2022.
  • 54 funds tracked by Wall St. Rank held Rallybio as of Q4 2023.

Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.